CAN
BMRN icon

Cetera Advisor Networks’s BioMarin Pharmaceuticals BMRN Stock Holding History

Cetera Advisor Networks’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$704K Sell
8,061
-570
-7% -$51K ﹤0.01% 1691
2023
Q4 		$832K Buy
8,631
+1,462
+20% +$129K ﹤0.01% 1496
2023
Q3 		$634K Sell
7,169
-496
-6% -$44.1K ﹤0.01% 1606
2023
Q2 		$664K Buy
7,665
+1,283
+20% +$121K ﹤0.01% 1537
2023
Q1 		$621K Sell
6,382
-750
-11% -$77.8K ﹤0.01% 1556
2022
Q4 		$738K Buy
7,132
+405
+6% +$38K 0.01% 1371
2022
Q3 		$570K Buy
6,727
+1,264
+23% +$113K 0.01% 1197
2022
Q2 		$453K Sell
5,463
-62
-1% -$4.94K 0.01% 1333
2022
Q1 		$426K Buy
5,525
+1,530
+38% +$128K 0.01% 1402
2021
Q4 		$353K Sell
3,995
-3,416
-46% -$282K ﹤0.01% 1508
2021
Q3 		$573K Buy
7,411
+849
+13% +$67K 0.01% 1139
2021
Q2 		$548K Buy
6,562
+3,866
+143% +$306K 0.01% 1118
2021
Q1 		$204K Buy
+2,696
New +$220K ﹤0.01% 1363
2020
Q3 		– Sell
-1,959
Closed -$242K – 1427
2020
Q2 		$242K Buy
+1,959
New +$195K 0.01% 1016
2019
Q4 		– Sell
-3,434
Closed -$232K – 1246
2019
Q3 		$232K Buy
3,434
+28
+0.8% +$2.16K 0.01% 1032
2019
Q2 		$293K Buy
+3,406
New +$291K 0.01% 919
2014
Q4 		– Sell
-8,200
Closed -$588K – 825
2014
Q3 		$588K Sell
8,200
-1,150
-12% -$75.6K 0.04% 406
2014
Q2 		$579K Buy
+9,350
New +$565K 0.04% 421
2014
Q1 		– Sell
-6,924
Closed -$489K – 781
2013
Q4 		$489K Sell
6,924
-350
-5% -$23.8K 0.04% 411
2013
Q3 		$524K Sell
7,274
-230
-3% -$15.3K 0.05% 343
2013
Q2 		$417K Buy
+7,504
New +$468K 0.04% 354

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cetera Advisor Networks's BMRN Position: Q1 2024 in Review

Cetera Advisor Networks reduced its BioMarin Pharmaceuticals (BMRN) stake by 6.6% in Q1 2024, selling an estimated $51K and leaving 8,061 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

Cetera Advisor Networks first reported a position in BMRN in Q2 2013 and has held it in 21 quarters since. The position peaked at $832K in Q4 2023. 561 funds tracked by Wall St. Rank hold BMRN as of Q1 2024.

  • Cetera Advisor Networks held 8,061 shares of BioMarin Pharmaceuticals worth $704K as of Q1 2024.
  • Cetera Advisor Networks sold 570 BioMarin Pharmaceuticals shares in Q1 2024, an estimated $51K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1691 holding.
  • Cetera Advisor Networks first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 21 quarters since.
  • Cetera Advisor Networks's BioMarin Pharmaceuticals position peaked at $832K in Q4 2023.
  • 561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.